Executive summary

Published in the Green Journal, this database study from Taiwan analyzed 982 patients with head and neck squamous cell carcinoma (HNSCC) treated with IMRT or PBT using 3:1 propensity score matching.

This study reported that patients who received PBT had significantly lower risks of all-cause mortality, cancer-specific death, and locoregional recurrence than those who received IMRT. The authors concluded that proton therapy is associated with superior outcomes for HNSCC compared to IMRT

Top cancer treatments